Syncrospas 100mg Capsule

Introduction

Syncrospas is a medication containing the active ingredient Fenoverine. It is available under the brand name Syncrospas. This medication is primarily used to treat gastrointestinal disorders and relieve associated symptoms.

Uses

Syncrospas is prescribed for the treatment of various gastrointestinal conditions, including irritable bowel syndrome (IBS) and functional abdominal pain. It helps reduce abdominal pain, cramps, bloating, and discomfort associated with these conditions.

Dosage and Administration

The recommended dosage of Syncrospas may vary depending on the individual’s age, condition, and response to treatment. Follow the instructions provided by your healthcare professional. Generally, the usual adult dose is one capsule taken three times a day, preferably before meals. For children, the dosage will be determined by the doctor based on their age and weight.

These capsules should be swallowed whole with a glass of water. Do not crush, chew, or break the capsules unless instructed to do so by your healthcare provider.

Mechanism of Action

Syncrospas contains Fenoverine, which works by relaxing the smooth muscles in the gastrointestinal tract. It acts locally to relieve spasms and reduce the associated symptoms. This mechanism of action helps improve the motility of the intestines and reduces pain and discomfort.

Side Effects

Common side effects may include dizziness, drowsiness, dry mouth, constipation, and blurred vision. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, consult your healthcare professional.

In rare cases, more serious side effects may occur. These may include severe allergic reactions, difficulty breathing, chest pain, irregular heartbeat, or swelling of the face, lips, tongue, or throat. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. This is because certain medications may interact with Syncrospas and affect its effectiveness or increase the risk of side effects. Common drug interactions may include certain antihistamines, sedatives, and medications that affect heart rhythm. Discuss any potential interactions with your healthcare provider before starting Syncrospas.

Precautions

Before taking Syncrospas, inform your healthcare provider about any pre-existing medical conditions, allergies, or sensitivities you may have. Disclose your complete medical history to ensure the safe and effective use of this medication.

Certain precautions should be taken while using Syncrospas. It is contraindicated in individuals with known hypersensitivity to Fenoverine or any other components of the medication. It should also be used with caution in individuals with certain medical conditions, such as liver or kidney disease, glaucoma, or urinary retention.

Syncrospas may cause drowsiness or dizziness. Avoid activities that require alertness, such as driving or operating machinery, until you know how the medication affects you.

Storage

Syncrospas should be stored at room temperature, away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use this medication after the expiration date printed on the packaging. If you have any expired or unused medication, dispose of it properly according to local regulations.

Patient Tips

Here are some additional tips for patients using Syncrospas:

• Take the medication as prescribed by your healthcare professional. Do not adjust the dosage or stop taking the medication without consulting your doctor.
• If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
• maintain a healthy lifestyle and follow a balanced diet while using Syncrospas. Avoid trigger foods that may worsen your gastrointestinal symptoms.
• If you have any concerns or questions about the medication, do not hesitate to contact your healthcare provider. They are the best resource for personalized advice and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Chariot P, Ratiney R, Le Maguet F, Fourestié V, Astier A, Gherardi R. Fenoverine-induced rhabdomyolysis. Hum Exp Toxicol. 1995 Aug;14(8):654-6. doi: 10.1177/096032719501400805. [Accessed 24 Jun. 2024] Available at:
• Cho J, Na J, Bae E, Lee TW, Jang HN, Cho HS, Chang SH, Park DJ. The incidence, risk factors, and clinical outcomes of rhabdomyolysis associated with fenoverine prescription: a retrospective study in South Korea (1999-2014). BMC Pharmacol Toxicol. 2020 Apr 25;21(1):30. doi: 10.1186/s40360-020-00408-3. [Accessed 2 Jun. 2024] Available at:
• Ratiney R, Astier A, Chariot P. Determination of fenoverine in tissue samples by high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1994 Mar 18;654(1):159-63. doi: 10.1016/0378-4347(94)00016-6. [Accessed 25 Jun. 2024] Available at:
• Gonella J, Lalanne C, Mironneau J. Fenoverine: a novel synchronizer of smooth muscle motility by interference with cellular calcium flow. Curr Med Res Opin. 1987;10(7):427-35. doi: 10.1185/03007998709112400. [Accessed 7 Jun. 2024] Available at: